Analyses of second-generation 'legal highs' in the UK: Initial findings

被引:192
作者
Brandt, Simon D. [1 ]
Sumnall, Harry R. [2 ]
Measham, Fiona [3 ]
Cole, Jon [4 ]
机构
[1] Liverpool John Moores Univ, Sch Pharm & Biomol Sci, Liverpool L3 3AF, Merseyside, England
[2] Liverpool John Moores Univ, Ctr Publ Hlth, Liverpool L3 3AF, Merseyside, England
[3] Univ Lancaster, Dept Appl Social Sci, Lancaster, England
[4] Univ Liverpool, Sch Psychol, Liverpool L69 3BX, Merseyside, England
关键词
naphyrone; legal high; NRG-1; NRG-2; mass spectrometry; forensic; clinical; cathinones; MS-MS; MEPHEDRONE;
D O I
10.1002/dta.155
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the UK, mephedrone and other so-called 'legal high' derivatives have recently been classified as Class B, Schedule I under the Misuse of Drugs Act 1971. Since then, alternative products have been advertised on a number of websites. In order to obtain an immediate snapshot of the situation, 24 products were purchased online from 18 UK-based websites over a period of 6 weeks following the ban in April 2010. Qualitative analyses were carried out by gas chromatography ion trap mass spectrometry using electron- and chemical ionization modes, nuclear magnetic resonance spectroscopy, and comparison with reference standards. Overall, the purchased products consisted of single cathinones or cathinone mixtures including mephedrone, butylone, 4-methyl-N-ethylcathinone, flephedrone (4-fluoromethcathinone) and MDPV (3,4-methylenedioxypyrovalerone), respectively. Benzocaine, caffeine, lidocaine, and procaine were also detected. The emphasis was placed on 'Energy 1' (NRG-1), a product advertised as a legal replacement for mephedrone-type derivatives usually claiming to contain naphyrone (naphthylpyrovalerone, O-2482). It was found that 70% of NRG-1 and NRG-2 products appeared to contain a mixture of cathinones banned in April 2010 and rebranded as 'new' legal highs, rather than legal chemicals such as naphyrone as claimed by the retailers. Only one out of 13 NRG-1 samples appeared to show analytical data consistent with naphyrone. These findings also suggest that both consumers and online sellers (unlike manufacturers and wholesalers) are, most likely unknowingly, confronted with the risk of criminalization and potential harm. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:377 / 382
页数:6
相关论文
共 17 条
  • [1] Fluoromethcathinone, a new substance of abuse
    Archer, R. P.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2009, 185 (1-3) : 10 - 20
  • [2] Synthesis of 2,3-and 3,4-methylenedioxyphenylalkylamines and their regioisomeric differentiation by mass spectral analysis using GC-MS-MS
    Borth, S
    Hänsel, W
    Rösner, P
    Junge, T
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2000, 114 (03) : 139 - 153
  • [3] Analytical chemistry of synthetic routes to psychoactive tryptamines -: Part II.: Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR
    Brandt, SD
    Freeman, S
    Fleet, IA
    McGagh, P
    Alder, JF
    [J]. ANALYST, 2005, 130 (03) : 330 - 344
  • [4] Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone
    Camilleri, Andrew
    Johnston, Martin R.
    Brennan, Michael
    Davis, Sean
    Caldicott, David G. E.
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2010, 197 (1-3) : 59 - 66
  • [5] The content of ecstasy tablets: implications for the study of their long-term effects
    Cole, JC
    Bailey, M
    Sumnall, HR
    Wagstaff, GF
    King, LA
    [J]. ADDICTION, 2002, 97 (12) : 1531 - 1536
  • [6] Methcathinone is a substrate for the serotonin uptake transporter
    Cozzi, NV
    Foley, KE
    [J]. PHARMACOLOGY & TOXICOLOGY, 2003, 93 (05): : 219 - 225
  • [7] Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines
    Cozzi, NV
    Sievert, MK
    Shulgin, AT
    Jacob, P
    Ruoho, AE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 381 (01) : 63 - 69
  • [8] The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs
    DalCason, TA
    [J]. FORENSIC SCIENCE INTERNATIONAL, 1997, 87 (01) : 9 - 53
  • [9] Fitzgerald J.L., 2002, CONTEMP DRUG PROBL, V29, P201
  • [10] Novel aminopropiophenones as potential antidepressants
    Foley, KF
    Cozzi, NV
    [J]. DRUG DEVELOPMENT RESEARCH, 2003, 60 (04) : 252 - 260